Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial.
Biondi-Zoccai GG, Valgimigli M, Sheiban I, Margheri M, Marzocchi A, Prati F, Vischi M, Lettieri C, Violini R, Sardella G, Stabile A, Clementi F, Romeo F, Colombo A, Sangiorgi G. Biondi-Zoccai GG, et al. Among authors: marzocchi a. J Cardiovasc Med (Hagerstown). 2008 Sep;9(9):957-62. doi: 10.2459/JCM.0b013e3282ffd3a6. J Cardiovasc Med (Hagerstown). 2008. PMID: 18695440 Clinical Trial.
A prospective multicentre observational study on the management of unprotected left main coronary artery disease: rationale and design of the Registro Italiano sul Trattamento del tronco comune non protetto study.
Sheiban I, Sillano D, Biondi-Zoccai GG, De Servi S, Tamburino C, Marzocchi A, Trevi GP, Moretti C. Sheiban I, et al. Among authors: marzocchi a. J Cardiovasc Med (Hagerstown). 2008 Aug;9(8):826-30. doi: 10.2459/JCM.0b013e3282fce7c0. J Cardiovasc Med (Hagerstown). 2008. PMID: 18607249
Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: the INtegrilin plus STenting to Avoid myocardial Necrosis Trial.
Biondi-Zoccai G, Valgimigli M, Margheri M, Marzocchi A, Lettieri C, Stabile A, Petronio AS, Binetti G, Bolognese L, Bellone P, Sardella G, Contarini M, Sheiban I, Marra S, Piscione F, Romeo F, Colombo A, Sangiorgi G. Biondi-Zoccai G, et al. Among authors: marzocchi a. Am Heart J. 2012 May;163(5):835.e1-7. doi: 10.1016/j.ahj.2012.02.009. Am Heart J. 2012. PMID: 22607870 Clinical Trial.
Antiplatelet therapy in patients undergoing coronary stent implantation: Italian Society of Interventional Cardiology consensus document.
Guagliumi G, Musumeci G, Rossini R, Bolognese L, Giordano A, Marzocchi A, Ramondo A, Sangiorgi G, Tamburino C, Tomai F, De Servi S. Guagliumi G, et al. Among authors: marzocchi a. J Cardiovasc Med (Hagerstown). 2007 Oct;8(10):782-91. doi: 10.2459/JCM.0b013e3282785250. J Cardiovasc Med (Hagerstown). 2007. PMID: 17885515 Review.
Temporal pattern of ischemic events in relation to dual antiplatelet therapy in patients with unprotected left main coronary artery stenosis undergoing percutaneous coronary intervention.
Palmerini T, Marzocchi A, Tamburino C, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Santarelli A, Bartorelli AL, Briguori C, Vignali L, Di Pede F, Ramondo A, Inglese L, De Carlo M, Bolognese L, Benassi A, Palmieri C, Filippone V, Sangiorgi D, Barlocco F, Lauria G, De Servi S. Palmerini T, et al. Among authors: marzocchi a. J Am Coll Cardiol. 2009 Apr 7;53(14):1176-81. doi: 10.1016/j.jacc.2008.12.034. J Am Coll Cardiol. 2009. PMID: 19341857 Free article.
Impact of bifurcation technique on 2-year clinical outcomes in 773 patients with distal unprotected left main coronary artery stenosis treated with drug-eluting stents.
Palmerini T, Marzocchi A, Tamburino C, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Santarelli A, Bartorelli A, Briguori C, Vignali L, Di Pede F, Ramondo A, Inglese L, De Carlo M, Falsini G, Benassi A, Palmieri C, Filippone V, Sangiorgi D, Barlocco F, De Servi S. Palmerini T, et al. Among authors: marzocchi a. Circ Cardiovasc Interv. 2008 Dec;1(3):185-92. doi: 10.1161/CIRCINTERVENTIONS.108.800631. Circ Cardiovasc Interv. 2008. PMID: 20031677
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial.
Ribichini F, Ansalone G, Bartorelli A, Beqaraj F, Berni A, Colangelo S, D'Amico M, Della Rovere F, Fiscella A, Gabrielli G, Indolfi C, La Vecchia L, Loschiavo P, Marinoni G, Marzocchi A, Milazzo D, Romano M, Sangiorgio P, Sheiban I, Tamburino C, Tuccillo B, Villani R, Cappi B, Quijada MJ, Vassanelli C; EXECUTIVE Trial Investigators. Ribichini F, et al. Among authors: marzocchi a. J Cardiovasc Med (Hagerstown). 2010 Apr;11(4):299-309. doi: 10.2459/JCM.0b013e3283331e69. J Cardiovasc Med (Hagerstown). 2010. PMID: 20090550 Clinical Trial.
Impact of acute coronary syndromes on two-year clinical outcomes in patients with unprotected left main coronary artery stenosis treated with drug-eluting stents.
Palmerini T, Sangiorgi D, Marzocchi A, Tamburino C, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Franco N, Bartorelli A, Briguori C, Vignali L, Di Pede F, Ramondo A, Medda M, De Carlo M, Bolognese L, Benassi A, Palmieri C, Filippone V, Lauria G, De Servi S. Palmerini T, et al. Among authors: marzocchi a. Am J Cardiol. 2010 Jan 15;105(2):174-8. doi: 10.1016/j.amjcard.2009.08.666. Am J Cardiol. 2010. PMID: 20102914
Sex-related differences in patients undergoing percutaneous unprotected left main stenting.
Sheiban I, La Spina C, Cavallero E, Biondi-Zoccai G, Colombo F, Palmerini T, Marzocchi A, Tamburino C, Margheri M, Vecchi G, Sangiorgi G, Santarelli A, Bartorelli AL, Briguori C, Vignali L, di Pede F, Ramondo A, Fantoni C, de Carlo M, Falsini G, Benassi A, Palmieri C, Filippone V, Sangiorgi D, de Servi S. Sheiban I, et al. Among authors: marzocchi a. EuroIntervention. 2010 Feb;5(7):795-800. doi: 10.4244/eijv5i7a133. EuroIntervention. 2010. PMID: 20142193
Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients.
Biondi-Zoccai G, Sheiban I, Moretti C, Palmerini T, Marzocchi A, Capodanno D, Tamburino C, Margheri M, Vecchi G, Sangiorgi G, Santarelli A, Bartorelli AL, Briguori C, Vignali L, Pede Fd, Ramondo A, Medda M, de Carlo M, Falsini G, Benassi A, Palmieri C, Filippone V, Sangiorgi D, Barlocco F, de Servi S. Biondi-Zoccai G, et al. Among authors: marzocchi a. Clin Res Cardiol. 2011 May;100(5):403-11. doi: 10.1007/s00392-010-0258-z. Epub 2010 Dec 3. Clin Res Cardiol. 2011. PMID: 21128078
231 results